Confirmed the efficacy of Saccharomyces boulardii

In April 2014, the working group of ESPGHAN (European Society of Gastroenterology, Hepatology and Nutrition Pediatric) published a Position Paper in which it is strongly recommended the use of Saccharomyces boulardii in the treatment of acute gastroenteritis in children on the basis numerous scientific evidence of recent years¹.

The previous ESPGHAN Guidelines of 2008 had already suggested for the treatment of this disease, so frequent in children, the exclusive use of probiotic strains with proven efficacy, such as Saccharomyces boulardii².

Fonts:

1. Szajewska, Guarino et al. On Behalf of the ESPGHAN Working group for Probiotic and Prebiotic. Use of Probiotics for the Management of acute gastroenteritis: a position paper by the ESPGHAN Working group for Probiotic and Prebiotic. JPGN 2014; 58: 531-539
2. Guarino et al. Evidence based guideline for the Management of acute gastroenteritis in children in Europe, JPGN 2008; 46:581-5122

The advice provided through this service do not address medical problems, contained indicative and do not consider any particular situation. The advice and the answers provided are not a substitute in any way medical advice which should always be consulted for any problem or need.